Results 181 to 190 of about 911,773 (309)

Safety and pharmacokinetics of a novel potent GABA analogue crisugabalin in Chinese subjects with various degrees of renal impairment

British Journal of Clinical Pharmacology, EarlyView.
Aims Crisugabalin is a novel calcium channel α2δ subunit ligand and a highly selective oral gamma‐aminobutyric acid (GABA) analogue developed for the treatment of diabetic peripheral neuropathic pain (DPNP) and postherpetic neuralgia (PHN). This study investigated pharmacokinetic properties and safety of crisugabalin in subjects with renal impairment ...
Shibeilei Lin, Ye Wang, Chao Hu, Yanhuan Feng, Xi Tang, Ping Fu, Jia Miao   +6 more
wiley   +1 more source

Innate and adaptive immune responses in Hepatitis C virus infections. [PDF]

Virus Res
Kishida Y.
europepmc   +1 more source

Naturally Occurring Hepatitis C Virus Subgenomic Deletion Mutants Replicate Efficiently in Huh-7 Cells and Are trans -Packaged In Vitro To Generate Infectious Defective Particles

, 2009
Laura Pacini, Rita Graziani, Linda Bartholomew, Raffaele De Francesco, Giacomo Paonessa   +4 more
openalex   +2 more sources

Maternal Risk Factors Associated with Inadequate Testing and Loss to Follow-up in Infants with Perinatal Hepatitis C Virus Exposure [PDF]

, 2017
Amrita Bhardwaj, Maroun J. Mhanna, Nazha Abughali   +2 more
openalex   +1 more source

Infection Risk From Humans and Animals in the Anatomy Laboratory: A Scoping Review

Clinical Anatomy, EarlyView.
ABSTRACT Whole‐body dissection is a cornerstone of anatomy education. During and following the COVID‐19 pandemic, exposure to infectious agents and other risks of dissection were highlighted. To identify potential risks, one must have the data outlining these risks in specific situations.
Margaret A. McNulty, Elizabeth R. Agosto
wiley   +1 more source

Sjögren's syndrome and hepatitis C virus infection presenting as hypokalemic quadriparesis: A case report. [PDF]

J Int Med Res
Joshi A, Risal UP, Sah NK, Shah B.
europepmc   +1 more source

Molecular markers of hepatitis C virus-related hepatocellular carcinoma [PDF]

, 2006
Ahmed Sultan, Saad M. El‐Gendy, Mohamed Hessien, El Sherbiny Mahmoud, Abdel Selam M. Ibrahim, Zaki A. Sherif   +5 more
openalex   +1 more source

Robust hepatitis C virus infection in vitro.

Proceedings of the National Academy of Sciences of the United States of America, 2005
Jin Zhong, P. Gastaminza, G. Cheng, S. Kapadia, Takanobu Kato, D. Burton, S. Wieland, S. Uprichard, T. Wakita, F. Chisari   +9 more
semanticscholar   +1 more source

Lipid Profile Differences in HIV‐Infected Populations With Metabolic Dysfunction‐Associated Steatotic Liver Disease: A Systematic Review and Meta‐Analysis

Chronic Diseases and Translational Medicine, EarlyView.
PRISMA study flow diagram. ABSTRACT Introduction Advances in HIV management have transformed HIV into a chronic condition, resulting in improved prognosis and increased survival among people living with HIV (PLWH). Traditional risk factors for metabolic dysfunction‐associated steatotic liver disease (MASLD)—including dyslipidemia—are prevalent in PLWH.
Yovita Hartantri, Sherly Lawrensia, Steven Yulius Usman, Nenny Agustanti, Rudi Wisaksana, Nanny Natalia Mulyani Soetedjo, Bachti Alisjahbana   +6 more
wiley   +1 more source

Conformational Trajectory of the Molecular Chameleon Grazoprevir from Formulation to Target‐Bound

Chemistry – A European Journal, EarlyView.
ABSTRACT Macrocycles represent a promising class of beyond‐rule‐of‐5 (bRo5) therapeutics, capable of targeting proteins traditionally considered undruggable by conventional small molecules. Macrocycles exhibit intrinsic flexibility and often display a “chameleon‐like” ability to adapt to their environment, thereby enhancing their oral bioavailability ...
Lianne H. E. Wieske, Guanhong Bu, Máté Erdélyi, Jan Kihlberg, Tamir Gonen, Emma Rova Danelius   +5 more
wiley   +1 more source